The Triumph of Hope Over Science
By Mark Derr,
New York Times
| 02. 24. 2004
After I was diagnosed with Parkinson's disease two years ago,
at the relatively young age of 52, I read everything I could
about the condition's usual "progression" — an
odd word for degeneration. The worst-case prognosis is grim:
a long slide into physical and mental incapacity.
That is not going to happen to me, I said, as I began measuring
my physical decline. I am young enough that I may be able to
benefit from advances in medicine, especially in brain research.
Maybe with new medications I would be able to put off taking
L-dopa, the best drug for Parkinson's but one that loses its
effectiveness over time. Surely better treatments will become
available, I told myself.
So why didn't I welcome the news that researchers in South
Korea were able to clone a human embryo and extract viable stem
cells from it? After all, one of the researchers said their
goal was "not to clone humans, but to understand the causes
of diseases" — and one of the diseases named most
often was Parkinson's. Scientists say they may one...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...